ARMP Stock Analysis: Buy, Sell, or Hold?
ARMP - Armata Pharmaceuticals, Inc. Common Stock
$5.05
0.51 (11.23%)
▲
5d:
-1.94%
30d:
-14.26%
90d:
-43.19%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
6d
Get Alerted When ARMP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARMP shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ARMP shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ARMP is currently trading at $5.05, which is considered fair relative to its 30-day fair value range of $4.24 to $5.97.
Technical Outlook: Technically, ARMP is in a strong downtrend. Immediate support is located at $4.36, while resistance sits at $5.50. The stock is showing strong short-term momentum, up 11.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+246.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARMP is in a strong downtrend. Immediate support is located at $4.36, while resistance sits at $5.50. The stock is showing strong short-term momentum, up 11.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+246.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.24 -
$5.97
Company Quality Score
46/100
(HOLD)
Options IV Signal
66th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 66th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.2%)
- BULLISH: Trading 246.5% below Wall St target ($17.50)
Trading Range Analysis
30-Day Trading Range
$4.24 -
$5.97
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$2.07
(40.9%)
Support & Resistance Levels
Support Level
$4.36
Resistance Level
$5.50
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.77
Wall Street Target
$17.50
(+246.5%)
Revenue Growth (YoY)
60.7%
Share & Embed Analysis
Last updated: August 03, 2026 9:43 PM ET
Data refreshes hourly during market hours. Next update: 10:43 PM
Data refreshes hourly during market hours. Next update: 10:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARMP showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 46 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$15 | 54 HOLD |
